The Digital Health Corner

MARCH 26, 2018

In this scenario, a patient can digitally determine who should have access to the medical record (and which portion), which person(s) or entities saw or modified the record (and what portion) and when. Herding a patient’s data from many sources into a single record has always been a lofty goal of digital health.

Digital Health 117

Digital Health Interoperability Life Science HIE 117

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development 128

Drug Development Pharmaceuticals Life Science Digital Health 128

Digital Health Global

JANUARY 9, 2024

The investment adds to a growing list of prominent digital health investors in Europe and the United States, including Nina Capital and Young Sohn, a co-founder of Veeva Systems. The funding speaks to the global nature of pre-approval access and its increasing importance in the drug development process. “

Pharmaceuticals 88

Pharmaceuticals Drug Development Digital Health Health Technology 88

Digital Health Global

SEPTEMBER 28, 2023

The new seed funding activity will therefore pave the way for the next generation of treatments and digital health, providing healthcare professionals with better tools to improve experiences and outcomes for patients. Since 2017 Debiopharm has invested in 15 AI and digital health companies, typically leading the investment rounds.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Life Science 88

Digital Health Today

FEBRUARY 24, 2020

The bill was reintroduced in the House in February 2017 as HR 1223 and in the Senate in June 2017 as S 1509 but we need to put some pressure on to get this voted on. On Digital Health Today, I leverage my experiences to help great leaders and innovators tell their stories and connect to users, investors and other stakeholders.

Digital Health 104

Digital Health Drug Development 104

Lloyd Price

JUNE 17, 2023

The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.

Digital Health 83

Digital Health Drug Development Telemedicine Telehealth 83

Digital Health Global

JUNE 2, 2024

About Massive Bio: Massive Bio’s vision is to cover entire Pharma value chain with disruptive solutions to improve entire ecosystem from drug development to commercialization.

Drug Development 88

Drug Development Pharmaceuticals Mental health Patient Experience 88